Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study
Status:
Completed
Trial end date:
2018-01-11
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if it is safe to receive methotrexate
through the fourth ventricle of the brain in patients with brain tumors.
Methotrexate is designed to block cancer cells from dividing, which may slow or stop their
growth and spread throughout the body. This may cause the cancer cells to die.